RBC Life Sciences CEO Clinton H. Howard Acquires 3,100 Shares (RBCL)
RBC Life Sciences (NASDAQ:RBCL) CEO Clinton H. Howard acquired 3,100 shares of the stock on the open market in a transaction dated Monday, June 2nd. The shares were purchased at an average cost of $0.60 per share, with a total value of $1,860.00. Following the purchase, the chief executive officer now directly owns 976,760 shares of the company’s stock, valued at approximately $586,056. The acquisition was disclosed in a legal filing with the SEC, which is available at this link.
Shares of RBC Life Sciences (NASDAQ:RBCL) opened at 0.60 on Friday. RBC Life Sciences has a 1-year low of $0.01 and a 1-year high of $0.29. The stock’s 50-day moving average is $0.14 and its 200-day moving average is $0.14. The company’s market cap is $1.3 million.
RBC Life Sciences, Inc (NASDAQ:RBCL) is principally engaged in the marketing and distribution of nutritional supplements and personal care products (collectively Nutritional Products) through subsidiaries in the United States and Canada and, effective October 1, 2011, a branch office in Taiwan.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.